# Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis

> **NCT00016458** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 20 (—)

## Conditions studied

- Systemic Sclerosis

## Interventions

- **DRUG:** anti-thymocyte globulin
- **DRUG:** cyclophosphamide

## Key facts

- **NCT ID:** NCT00016458
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00016458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00016458, "Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00016458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*